Key Takeaways
- • Chicago Pacific Founders Pet Fund has exited its investment in CoVet, a Hamilton, Ontario-based veterinary software company, through a sale to IDEXX—a major consolidation move in the veterinary tech sector.
- • CoVet operates an AI-powered clinical scribe and workflow platform serving veterinary practices across North America and Europe, addressing a growing demand for practice management automation in animal healthcare.
- • The exit represents a portfolio milestone for the Chicago Pacific venture fund, though specific deal valuation and transaction timing details are not disclosed in available sources.
- • IDEXX's acquisition of CoVet signals continued M&A activity in veterinary software and digital health solutions, where practice efficiency and AI-driven tools are becoming competitive differentiators.
Summary
Chicago Pacific Founders Pet Fund has completed its exit from CoVet, a veterinary software company based in Hamilton, Ontario, through a sale to IDEXX. The transaction marks a notable consolidation event in the specialized veterinary technology market, where software solutions addressing clinical workflows and practice management have attracted significant investment attention.
CoVet develops an AI-powered clinical scribe and workflow optimization platform designed for veterinary practices operating across North America and Europe. The platform addresses operational efficiency challenges in animal healthcare settings, where practice management automation and clinical documentation tools have become increasingly important as veterinary businesses scale and seek to reduce administrative burden on veterinarians and support staff.
The sale to IDEXX, a global leader in veterinary diagnostics and software solutions, reflects broader industry trends toward consolidation of point-solution veterinary software providers into larger, integrated platforms. IDEXX's acquisition strategy in recent years has focused on expanding its software and services portfolio to create more comprehensive practice management ecosystems for veterinary clinics.
Chicago Pacific's exit from CoVet demonstrates investor appetite for exits in the veterinary healthcare technology space, where growth tailwinds from pet ownership trends, increased spending on pet healthcare, and digitalization of veterinary practices continue to attract capital. The fund's successful realization of this investment aligns with the broader venture capital thesis around specialized B2B software serving underserved professional services markets.
Specific valuation metrics and the full terms of the transaction were not disclosed in available reporting.
CoVet develops an AI-powered clinical scribe and workflow optimization platform designed for veterinary practices operating across North America and Europe. The platform addresses operational efficiency challenges in animal healthcare settings, where practice management automation and clinical documentation tools have become increasingly important as veterinary businesses scale and seek to reduce administrative burden on veterinarians and support staff.
The sale to IDEXX, a global leader in veterinary diagnostics and software solutions, reflects broader industry trends toward consolidation of point-solution veterinary software providers into larger, integrated platforms. IDEXX's acquisition strategy in recent years has focused on expanding its software and services portfolio to create more comprehensive practice management ecosystems for veterinary clinics.
Chicago Pacific's exit from CoVet demonstrates investor appetite for exits in the veterinary healthcare technology space, where growth tailwinds from pet ownership trends, increased spending on pet healthcare, and digitalization of veterinary practices continue to attract capital. The fund's successful realization of this investment aligns with the broader venture capital thesis around specialized B2B software serving underserved professional services markets.
Specific valuation metrics and the full terms of the transaction were not disclosed in available reporting.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.